The crackdown comes at a time when GLP-1 drugs, widely used for weight loss and diabetes, are seeing a surge in demand, but are increasingly being accessed without proper prescriptions through retail and digital channels.

The Centre has intensified its crackdown on the misuse and unauthorised sale of popular weight-loss and diabetes drugs, amid growing concerns over their easy availability across online platforms, pharmacies, and wellness clinics, triggering fears of unsupervised use and serious health risks.

The Drug Controller General of India (DCGI), along with State Drug Controllers, has carried out inspections across the country, auditing 49 businesses including online pharmacy warehouses, wholesalers, retailers and weight-loss clinics.

Notices have been issued for violations, with officials warning that "non-compliance will result in licence cancellation, fines, and legal action."

The crackdown comes at a time when GLP-1 drugs, widely used for weight loss and diabetes, are seeing a surge in demand, but are increasingly being accessed without proper prescriptions through retail and digital channels.

Authorities have flagged concerns over "on-demand availability" and potential misuse, prompting stricter surveillance.

Source:Ndtv